PTPRC and Patent ductus arteriosus: As there was no validated antibody for human ARG1 available, we performed ARG1 RNA in situ hybridization in human PDA, together with co-immunofluorescence staining for the immune cell marker CD45 and for the epithelial cell marker E-cadherin (ECAD) (Figure 1A).